Global Tumor Mice Model Market Growth 2025-2031

The global Tumor Mice Model market size is predicted to grow from US$ 2064 million in 2025 to US$ 3071 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.

A tumor mouse model, also known as a mouse xenograft model, is an experimental system where human tumor cells or tumor tissues are transplanted into immunodeficient mice. This model is widely used in cancer research to study tumor biology, test potential therapies, and understand the mechanisms of tumor growth, progression, and response to treatment.

Syngeneic mice retain an intact immune system; therefore, they are specifically used in immune-oncology studies. Cancer immunotherapies are designed to work in conjunction with a patient’s immune system to increase natural anti-tumor response.Oncology Mice Models Market Segmented By Humanized Immune System Mice Models, Syngeneic Tumor Mice Models, Immunodeficient Mice Models, NOG Mice Models, Spontaneous Tumor Mice Models Product

The global tumor mice model market refers to the market for mouse models used in cancer research, specifically for studying tumor biology, testing potential cancer therapies, and understanding tumor growth and progression. This market encompasses various aspects, including the supply of tumor mice models, associated products and services, and research collaborations.

The tumor mice model market has been growing significantly in recent years due to the increasing demand for better understanding of cancer biology and the development of targeted therapies. Key factors driving the growth of this market include:

Rising Incidence of Cancer: The increasing prevalence of cancer worldwide has driven the demand for tumor mice models to study different types of cancer, test potential treatments, and explore personalized medicine approaches.

Advancements in Cancer Research: Continuous advancements in cancer research have led to a greater focus on understanding tumor biology, treatment response, and resistance mechanisms. Tumor mice models provide a valuable tool for conducting preclinical studies, facilitating drug discovery and development.

Growing Investments in Research and Development: Governments, academic institutions, and pharmaceutical/biotechnology companies are investing heavily in cancer research and drug development. This has led to increased funding for tumor mice models and related research initiatives.

Rise of Precision Medicine and Personalized Therapies: The emergence of precision medicine, which aims to tailor treatments based on individual genetic profiles and tumor characteristics, has further driven the demand for tumor mice models to study tumor heterogeneity and develop personalized therapies.

Collaborations and Partnerships: Research organizations and pharmaceutical companies often collaborate with suppliers of tumor mice models to access customized mouse models or obtain specialized services, fostering growth in the market.

Key players in the tumor mice model market include suppliers of tumor mice models and associated services. These companies provide a range of mouse models, including patient-derived xenograft (PDX) models, genetically engineered models, cell line-derived xenograft (CDX) models, and others.

Additionally, companies providing related products and services such as breeding and maintenance of mouse colonies, genetic characterization, preclinical imaging services, and contract research organization (CRO) services contribute to the overall tumor mice model market.

The tumor mice model market is expected to continue growing as cancer research advances and personalized medicine approaches become more prominent.

LP Information, Inc. (LPI) ' newest research report, the “Tumor Mice Model Industry Forecast” looks at past sales and reviews total world Tumor Mice Model sales in 2024, providing a comprehensive analysis by region and market sector of projected Tumor Mice Model sales for 2025 through 2031. With Tumor Mice Model sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Mice Model industry.

This Insight Report provides a comprehensive analysis of the global Tumor Mice Model landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Mice Model portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Mice Model market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Mice Model and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Mice Model.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Mice Model market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Humanized Immune System Mice Models

Syngeneic Tumor Mice Models

Immunodeficient Mice Models

NOG Mice Models

Spontaneous Tumor Mice Models

Others

Segmentation by Application:

Contract Research Organizations

Pharma and Biopharma Companies

Academic and Research Institutes

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

The Jackson Laboratory

Taconic Biosciences

Charles River Laboratories

Shanghai Model Organisms Center Inc.

Envigo

Biocytogen

Genoway

Crown Bioscience Inc.

Cyagen

Applied Stem Cells

Ingenious Targeting Laboratory

PolyGene-Transgenic mice model company

Creative Biolabs

TransCure Bioservices

Champions Oncology Inc

Certis Oncology

Signature

Pharmaron

Laboratory Corporation of America Holdings

Gempharmatech

Janvier Labs

Harbour BioMed

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tumor Mice Model market?

What factors are driving Tumor Mice Model market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tumor Mice Model market opportunities vary by end market size?

How does Tumor Mice Model break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.